Almac: A global leader in drug development powered by the Dublin-Belfast Corridor

Almac, a privately owned, award-winning provider of comprehensive pharmaceutical services, has become a global leader in its industry.

With over 55 years of expertise, the company collaborates with the world’s top 25 pharmaceutical companies, delivering innovative services that span the entire drug development lifecycle, from discovery to commercialisation.

The Dublin-Belfast corridor, a critical transport and business hub, supports Almac to effectively manage and expand its global supply chain, positioning it to meet the needs of its international client base.

This dynamic region provides exceptional connectivity to key markets across Europe, the US and beyond, making it an ideal hub for the company’s global operations.

Almac is committed to a diverse and high-performing global workforce, employing over 7,500 people in 18 locations across Europe, the US and Asia, the company invests heavily in employee development, learning and growth.

Almac’s forward-thinking approach to business is a significant driver behind its international growth and industry leadership.

The company has consistently embraced innovation, operational excellence and sustainability, ensuring it remains at the forefront of the pharmaceutical sector.

This is particularly evident in its commitment to environmental, social and governance (ESG) practices, which are deeply embedded in the company’s culture.

Almac’s proactive approach to sustainability has progressed considerably to include a landmark virtual power purchase agreement with a wind farm to supply renewable electricity to its Craigavon headquarters – a key step towards meeting the company’s ambitious emissions reduction and net zero goals.

Almac is dedicated to engaging with the communities it serves, having reached more than 17,000 young people through outreach programmes and supported over 60 charities globally in the past year.

With its global footprint, commitment to sustainability and exceptional workforce, Almac is defining the future of drug development while making a significant positive impact on global health.